Medivie Therapeutic Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was ILS 491,000 compared to ILS 486,000 a year ago. Operating loss was ILS 7.116 million compared to ILS 17.165 million a year ago. Net loss was ILS 6.594 million compared to ILS 11.578 million a year ago. Basic loss per share from continuing operations was ILS 2.64 compared to ILS 5.3 a year ago.